Skip to main content

Table 2 Test Results of BMSCs Surface Molecular Marker (CD45, CD90)

From: Antitumor effect of IL-12 gene-modified bone marrow mesenchymal stem cells combined with Fuzheng Yiliu decoction in an in vivo glioma nude mouse model

Surface marker

F0-2

F0-3

F0-4

F0-5

F0-6

F0-7

F0-8

F0-9

F1-7

F2-7

F3-7

CD45 (%)

65.3

68.4

0.1

1.9

0.3

0.8

0.0

0.0

0.0

0.0

0.0

CD90 (%)

5.8

3.5

6.9

12.0

22.8

61.8

83.8

89.0

94.0

94.9

97.0